Biomarkers in Pharmacogenomics examines the role of biological markers in predicting drug responses and therapeutic outcomes. It covers the discovery, validation, and application of genetic, proteomic, and metabolomic biomarkers. The book highlights their significance in personalized medicine and drug development processes. Designed for researchers and clinicians, it provides comprehensive insights into biomarker-driven pharmacogenomics.
Megan Morris focuses on identifying biomarkers in pharmacogenomics to predict patient responses to dermatological treatments. Her research explores genetic markers that can guide the selection and dosing of medications for conditions like psoriasis and eczema. Megan has published extensively on the development and validation of biomarkers to enhance personalized dermatological therapy. She also provides guidelines for clinicians to utilize biomarker-based pharmacogenomic strategies, promoting more accurate and effective personalized care in dermatology through genetic and molecular insights.